Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR17 | Q13304 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | DAO | P14920 | 1/20 | 0.32 |
| ▸ | TGM2 | P21980 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
| ▸ | AHR | P35869 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29507649 | 1.00 | GPR17 (0.43) | GPR17KDM4EDAOTGM2CES2 | |
| SCHEMBL28050771 | 0.80 | MEN1 (0.46) | KDM4EDAOMEN1KMT2AGPR84 | |
| SCHEMBL26367026 | 0.79 | ALDH1A1 (0.48) | KDM4EMEN1KMT2AAHR | |
| SCHEMBL31219143 | 0.79 | KDM4E (0.47) | KDM4EAHR | |
| SCHEMBL29623038 | 0.79 | ALDH1A1 (0.48) | KDM4EMEN1KMT2AAHR | |
| SCHEMBL29909606 | 0.75 | GPR17 (0.40) | GPR17KDM4EKMT2A | |
| SCHEMBL28050860 | 0.74 | KIF11 (0.56) | KDM4EMEN1KMT2A | |
| SCHEMBL31219018 | 0.73 | ADORA3 (0.50) | — | |
| SCHEMBL31219097 | 0.73 | MAPK14 (0.40) | GPR17 | |
| SCHEMBL25723813 | 0.73 | MEN1 (0.37) | GPR17MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114163379-A | Fluorocarbazolyl diphenylethylene biphenyl compound and preparation method and application thereof | 闽都创新实验室 | 2022-03-11 | — | — | CN | disclosed |